Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 25;18(1):45.
doi: 10.1186/s13020-023-00749-1.

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection

Yanqi Han  1 , Jun Xu  1 , Qiang Zhu  2 , Li Yang  2 , Yitao Wang  3 , Hua Luo  4 , Tiejun Zhang  5
Affiliations
Review

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection

Yanqi Han et al. Chin Med. .

Abstract

Shufeng Jiedu Capsule (SFJDC), composed of eight herbs, is a big brand traditional Chinese medicine (TCM) for the treatment of different respiratory tract infectious diseases with good clinical efficacy and few side effects. It is clinically applied to acute upper respiratory tract infection(URI), influenza, acute exacerbation of chronic obstructive pulmonary disease (AECOPD), community-acquired pneumonia(CAP) and other diseases, due to its antibacterial, antiviral, anti-inflammatory, immunoregulatory and antipyretic activities. In particular, it has shown good clinical effects for COVID-19, and was included in the fourth to tenth editions of the 'Diagnosis and Treatment Protocol for COVID-19 (Trial)' by the National Health Commission. In recent years, studies on the secondary development which focus on the basic and clinical application of SFJDC have been widely reported. In this paper, chemical components, pharmacodynamic material basis, mechanisms, compatibility rule and clinical application were systematically summarized, in order to provide theoretical and experimental basis for further research and clinical application of SFJDC.

Keywords: Big brand traditional Chinese medicine; Respiratory tract infections; Secondary development of TCM; Shufeng Jiedu Capsule; Systematical research.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Summary of ‘herb-prescription-blood’ components of SFJDC
See this image and copyright information in PMC

References

    1. Li YX. Clinical curative effect observation of Shufeng Jiedu capsule on wind-heat cold. Clin J Tradit Chin Med. 2015;27(05):674–675.
    1. Hu R, Wang LH, Zhang JJ, et al. Clinical observation of Shufeng Jiedu Capsule for treating acute pharyngitis. Drug Eval Res. 2014;37(05):460–462.
    1. Ren H, Jiang Y, Wang S, et al. Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis. Medicine. 2021;100(1):e24198. doi: 10.1097/MD.0000000000024198. - DOI - PMC - PubMed
    1. Hu XY, Oliver T, Willcox M, et al. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial. Pilot Feasibility Stud. 2022;8(1):262. doi: 10.1186/s40814-022-01224-8. - DOI - PMC - PubMed
    1. Zhang XW, Xia RY, Gao JQ, et al. Chinese patent medicine Shufeng Jiedu Capsules as an adjuvant therapy for community-acquired pneumonia: a systematic review and meta-Analysis of randomized clinical trials. Front Pharmacol. 2022;13:923395. doi: 10.3389/fphar.2022.923395. - DOI - PMC - PubMed

LinkOut - more resources